Population Council: Clinical Trials

53 trials sponsored by Population Council, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 5 unknown, 2 recruiting. 22 Not applicable, 13 Phase 1, 12 Phase 2, 4 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 18, Unknown 3, Recruiting 1
Phase 113Completed 11, Unknown 2
Phase 212Completed 11, Unknown 1
Phase 34Completed 4
Early Phase 11Recruiting 1
Phase 41Completed 1

Follow Population Council: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
Pro-type IVR - Contraceptive Usage
Early Phase 1RecruitingPopulation Council602025-08-082025-09-05
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
ARROW strategies, One-time education - Cervical Cancer, Kaposi Sarcoma
Not applicableRecruitingImplenomics41002024-05-012026-11-04
Forging Hopeful Futures to Reduce Youth Violence
Forging Hopeful Futures, Wellness Check-ins - Violence in Adolescence, Racism
Not applicableCompletedUniversity of Pittsburgh5422023-07-102026-09-03
A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Dual Prevention Pill, PrEP and combined oral contraceptive (COC) as two separate tablets - HIV Infections, Contraception
Not applicableCompletedPopulation Council302022-12-072024-02-06
Pilot Study on Engaging Family Physicians in Family Planning in Pakistan
FP Training and Technical Support - Contraceptive Usage, Contraception
Not applicableUnknownPopulation Council762022-11-212022-12-13
A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Dual Prevention Pill, PrEP tablet and a COC as two separate tablets - HIV Infections
Not applicableUnknownPopulation Council962022-09-132024-02-06
A Crossover Study Evaluating 3 Non-medicated Silicone IVRs
Impact of ring size on adherence - Hiv, Pregnancy Related
Not applicableCompletedPopulation Council482022-01-202023-02-09
Integrated Care Delivery of HIV Prevention and Treatment in AGYW in Zambia
SHIELD intervention (Support for HIV Integrated Education, Linkages to care, and Destigmatization), Integrated wellness care (IWC) clinics - HIV
Not applicableCompletedRTI International21502021-05-102025-09-15
A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg
Levonorgestrel 1.5mg - Pregnancy Related
CompletedCamber Collective19802019-10-012021-11-05
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
Nestorone + Testosterone Combination Gel - Healthy, Men
Phase 2CompletedPremier Research4202018-10-252025-02-18
Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa
ShangRing, Mogen clamp - Circumcision
Not applicableCompletedWeill Medical College of Cornell University13802018-10-012021-03-04
Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy
The CHARM2 Intervention - Contraception
Not applicableCompletedUniversity of California, San Diego24022018-06-072022-09-06
Addressing Reproductive Coercion in HEalth Settings - Kenya
ARCHES Kenya - Unintended Pregnancy, Family Planning
Not applicableCompletedUniversity of California, San Diego6592018-06-012023-02-13
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
NES-E2 CVR - Healthy Women, Female Contraception
Phase 2CompletedPremier Research3852018-02-122025-10-31
Project YES! Youth Engaging for Success
Project YES! Youth Engaging for Success - HIV/AIDS
Not applicableCompletedJohns Hopkins Bloomberg School of Public Health2762017-12-152019-10-07
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women
Griffithsin Gel, Placebo Gel - HIV Infection
Phase 1CompletedPopulation Council152017-10-012018-11-27
Girl Empower: Studying the Impact of Mentorship, Asset Building, Caregiver Discussion Groups, and Cash Transfers on Reducing Girl's Vulnerability to Sexual Exploitation and Abuse
Girl Empower Program - Adolescent Behavior, Sexual Violence
Not applicableUnknownPopulation Council22002017-07-122018-11-29
Universal Coverage of Antiretroviral Treatment in Senegal
Case management - HIV/AIDS
Not applicableCompletedJohns Hopkins Bloomberg School of Public Health5962017-06-052022-10-07
A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)
Ulipristal Acetate IUS delivering Cu and 5μg, Ulipristal Acetate IUS delivering Cu and 20μg, Ulipristal Acetate IUS delivering Cu and 40μg - Contraception
Phase 1UnknownPopulation Council302017-05-012017-08-15
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males
Nestorone + Testosterone Combination Gel - Healthy Men, Male Contraception
Phase 1CompletedKimberly Myer262017-01-012026-02-09

Showing 20 of 53. Sign in to see all of them.

Conditions studied

HIV Infections (9)  ·  Acquired Immunodeficiency Syndrome (6)  ·  Sexually Transmitted Diseases (4)  ·  Coitus (3)  ·  Syphilis (3)  ·  Trichomonas Vaginitis (3)  ·  Adolescent Behavior (2)  ·  Contraception Behavior (2)  ·  HIV Seropositivity (2)  ·  Alcohol Drinking (1)  ·  Communication (1)  ·  Herpes Simplex (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Maternal Death (1)  ·  Multiple Endocrine Neoplasia Type 1 (1)

Interventions

ST 1435 (7)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Ethinyl Estradiol (2)  ·  Levonorgestrel (2)  ·  Palliative Care (2)  ·  Ambulatory Care Facilities (1)  ·  Behavior Therapy (1)  ·  Case Management (1)  ·  Contraceptives, Oral, Combined (1)  ·  Gels (1)  ·  Methods (1)  ·  Moxifloxacin (1)  ·  Organization and Administration (1)  ·  Testosterone (1)  ·  segesterone acetate and ethinyl estradiol vaginal system (1)

Countries

United States (21)  ·  Dominican Republic (6)  ·  Chile (5)  ·  India (4)  ·  South Africa (4)  ·  Zambia (4)  ·  Kenya (3)  ·  Thailand (3)  ·  Zimbabwe (3)  ·  Pakistan (2)  ·  Sweden (2)  ·  Tanzania (2)  ·  Australia (1)  ·  Brazil (1)  ·  Eswatini (1)

Top investigators

Barbara Friedland, MPH (4)  ·  Anita Raj, PhD (3)  ·  Christina Wang, MD (2)  ·  Niranjan Saggurti, PhD (2)  ·  Regine Sitruk-Ware, MD (2)  ·  Ruth Merkatz, Ph.D. (2)  ·  Alison Culyba, MD PhD MPH (1)  ·  Appolinaire Tiam, MD (1)  ·  Avina Sarna, MD (1)  ·  Ayaz Ahmed Baloch (1)  ·  Bradley Anawalt, MD (1)  ·  Bruce Bvulani, MBChB, MMed (1)  ·  Catherine McClean (1)  ·  Charlotte E. Ellertson, MPA, Ph.D. (1)  ·  Craig Hoesley, MD (1)

Results publications

PMID 26267119, PMID 31231065, PMID 31398307, PMID 38295968, PMID 38479746, PMID 18193495, PMID 19059048, PMID 20098295, PMID 21915249, PMID 23148456, PMID 24607560, PMID 24795094, PMID 24993487, PMID 25976760, PMID 26032952, PMID 26381120, PMID 26438349, PMID 26563220, PMID 26830816, PMID 26897656, PMID 27167981, PMID 28679389, PMID 28873452, PMID 28930059, PMID 28993911, PMID 29097225, PMID 29269252, PMID 29315327, PMID 29500162, PMID 30180845, PMID 30245866, PMID 30349875, PMID 30556332, PMID 31584004, PMID 32026250, PMID 32240186, PMID 32266327, PMID 32322807, PMID 32460786, PMID 32608505, PMID 32793878, PMID 32813276, PMID 33251157, PMID 33428559, PMID 34014429, PMID 34193214, PMID 35051209, PMID 35274093, PMID 36113534, PMID 36328094

NIH funding

1UG3HD096908-01 (1), R01AI045468 (1), R01CE003502 (1)